Viewpoints: Improving Drug Prices; Bundling Payments For Hip And Knee Replacements
A selection of opinions on health care from around the country.
The independent source for health policy research, polling, and news.
40,201 - 40,220 of 112,469 Results
A selection of opinions on health care from around the country.
Each week, KHN compiles a selection of recently released health policy studies and briefs.
Health care stories are reported from Texas, California, Minnesota, New York, Massachusetts, Maryland and North Carolina.
Activists in Washington state are asking for data from abortion clinics on womens' ages, races, length of pregnancy and how past pregnancies ended, as well as where the women lived. And they literally go through the clinic trash sometimes to find such patient information.
News outlets also report on Medicaid developments in Florida and Iowa.
On the Democratic side of the presidential race, Hillary Clinton calls out the Republican candidates for what she alleges are their "extreme views" about women.
The program, known as the 340B program, would tighten control on the deep discounts that some patients, drugs and providers get.
The trend is viewed as good news by health care professionals. In related news, the latest data shows that California lags behind other states in vaccination rates.
The use of terms like “additive-free,” “natural” or "organic" on labels violates federal law, the Food and Drug Administration warned the owners of Winston, Natural American Spirit and Nat Sherman brands in a letter.
In another fraud scheme, four people in New York plead guilty for filing $4 million in false Medicare claims.
Planned Parenthood sent to members of Congress a detailed letter and an accompanying report defending its practices and alleging that a string of eight undercover videos was heavily altered.
The judge said the ruling will be on the Republican legislators' request to temporarily bar the Medicaid expansion while legal questions are fully argued. Also in the news, a look at how flexible spending accounts may be affected by the "Cadillac tax" and an analysis of the fiscal problems of the insurance co-ops set up in the health law.
The increases range from 40 percent for two companies in Alaska to about 4 percent for the average rise in Washington state.
Amgen's Repatha, the second in a class of new, expensive biotech drugs approved by the Food and Drug Administration over the last month, targets artery-clogging cholesterol that cannot be treated as effectively by traditional statin medications.
The program, which provides long-acting reversible contraceptives to low-income and uninsured teenagers and women, received $2 million in support from private foundations, which is enough to keep it operating for at least one year. In other news, an Alaska state court judge ruled that a state law defining what qualifies -- for the purposes of Medicaid funding -- as a medically necessary abortion is unconstitutional.
Today's early morning highlights from the major news organizations.
A selection of opinions on health care from around the country.
Each week, KHN's Shefali Luthra finds interesting reads from around the Web.
Health care stories are reported from Oklahoma, Florida, California and Illinois.
Elsewhere, officials in Texas are reviewing proposed cuts to Medicaid, but are likely to keep them. The move would affect therapy for children. In other Medicaid news, Iowa and Minnesota consider bids to run parts of their Medicaid programs, and Illinois cuts heroin addiction treatment in Medicaid from a bill to address the problem.
© 2026 KFF